Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease?
- 31 December 1998
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 149 (9) , 804-810
- https://doi.org/10.1016/s0923-2494(99)80008-x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Tumor Necrosis Factor α and Lymphotoxin α Are Not Required for Induction of Acute Experimental Autoimmune EncephalomyelitisThe Journal of Experimental Medicine, 1997
- Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro.Journal of Clinical Investigation, 1996
- Tumour necrosis factor‐alpha (TNF‐α): The good, the bad and potentially very effectiveImmunology & Cell Biology, 1996
- The Tumor Necrosis Factor Ligand and Receptor FamiliesNew England Journal of Medicine, 1996
- Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic proteinNature, 1996
- Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in LymphotoxinScience, 1994
- Perforin and Tumor Necrosis Factor α in the Pathogenesis of Experimental Allergic Encephalomyelitis: Comparison of Autoantigen Induced and Transferred Disease in Lewis RatsJournal of Autoimmunity, 1993
- Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitisCellular Immunology, 1991
- Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.The Journal of Experimental Medicine, 1989
- Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtypeCellular Immunology, 1989